Search
Collplant Biotechnologies Ltd
CLGNAdd to Watchlist
3.750USD
-0.290-7.18%
Market hours 09/24, 10:21（ET）
70.91MMarket Cap
LossP/E TTM
Collplant Biotechnologies Ltd (CLGN) Revenue Performance
Updated: Dec 31, 2025Last year, Collplant Biotechnologies Ltd generated 2.00M USD for its biggest-performing segment, Revenues from licensing agreement. The United States made the largest contribution, accounting for 2.18M USD last year. For the latest quarter, Collplant Biotechnologies Ltd reported the revenue of 179.00K USD for the period ending 2025-06-30, which came from the top-performing segment, Revenues from the sales of goods. Northern America contributed the highest revenue, at 159.00K USD.
By Business
Revenue
Proportion
Annual
Annual
Quarterly
Revenues from licensing agreement
Revenues from the sales of goods
Revenues from the rendering of services
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Revenues from licensing agreement
2.00M(84.35%)
--(--)
10.00M(91.25%)
--(--)
14.00M(89.51%)
3.60M(58.66%)
Revenues from the sales of goods
371.00K(15.65%)
515.00K(100.00%)
959.00K(8.75%)
299.00K(100.00%)
1.59M(10.20%)
2.11M(34.35%)
Revenues from the rendering of services
--(--)
--(--)
--(--)
--(--)
46.00K(0.29%)
429.00K(6.99%)
By Region
Revenue
Proportion
Annual
Annual
Quarterly
United States
Europe
Canada
Israel
Canada
United States & Canada
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
United States
2.18M(91.78%)
484.00K(93.98%)
10.84M(98.91%)
--(--)
--(--)
--(--)
--(--)
Europe
98.00K(4.13%)
--(--)
28.00K(0.26%)
125.00K(41.81%)
628.00K(4.02%)
369.00K(6.01%)
240.00K(10.35%)
Canada
96.00K(4.05%)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
Israel
1.00K(0.04%)
31.00K(6.02%)
5.00K(0.05%)
--(--)
--(--)
--(--)
--(--)
Canada
--(--)
--(--)
87.00K(0.79%)
--(--)
--(--)
--(--)
--(--)
United States & Canada
--(--)
--(--)
--(--)
174.00K(58.19%)
15.01M(95.98%)
5.77M(93.99%)
2.08M(89.65%)